Varian’s Managed Services/IT Offering Reduces Risk and Boosts Resources for NHS Foundation Trust

Centerline

Never has the radiotherapy IT environment looked so complex, with busy staff under pressure to keep ever-evolving systems updated, secure, compliant, and highly available.

Read more

Varian’s Noona® ePRO Solution Improves Symptom Reporting for Breast Cancer Patients Receiving Radiotherapy

Centerline

Clinical studies have shown that the use of electronic patient reported outcomes (ePRO) tools in cancer care can result in significant benefits.

Read more

A New White Paper Shows: NOONA® Patient Engagement Platform is Intuitive and Easy-to-Use for Patients of all Ages

Centerline

Noona is a cloud-based mobile service that enables patients to have real-time communication with their clinical care teams and to report on treatment-related symptoms that, if left unaddressed, can result in distress and, in some cases, hospitalization.

Read more

Cryoablation Innovation Shows Promising Real-World Results

Centerline

Navid Eghbalieh, MD, Medical Director of Vascular & Interventional Radiology at Providence Holy Cross Medical Center, and Assistant Clinical Professor of Vascular & Interventional Radiology at UCLA, shared his experiences with the Varian CryoCare system u...

Read more

The Impact of COVID-19 on Lung Cancer Treatment in Europe

Centerline

Prior to the pandemic, lung cancer was the leading cause of cancer deaths worldwide. Without addressing the impact of COVID-19 on lung cancer services and ensuring long-term resilience, report shows how that trend looks set to increase.

Read more

Putting Patient Safety Front and Center with IDENTIFY

Centerline

As part of its ongoing commitment to Intelligent Cancer Care, Varian combines innovation with advances in patient identification, safety, and motion tracking to offer a comprehensive patient guidance system. The Varian IDENTIFY™ system is incorporated wit...

Read more

Brachytherapy Applicators for Gynecological Treatment: No Longer One-Size-Fits-All

Centerline

In the US alone, more than 110,000 new cases of gynecological cancer are diagnosed each year, with more than 32,000 deaths, according to the American Cancer Society.

Read more

Varian’s Adaptive Intelligence Consortium Amassing Clinical Evidence

Centerline

In April 2019, Varian announced the formation of the Adaptive Intelligence™ Consortium (AIC), a global community of clinicians and scientists from leading cancer clinics working to develop best practices for adaptive radiotherapy based on clinical evidenc...

Read more

HyperArc Proves Itself in Study after Study: A Brief Survey of Recent Literature

Centerline

When a new treatment technology comes on the scene, clinicians naturally want to be assured that it meets or exceeds the performance of established and familiar ones. Since HyperArc® high-definition radiotherapy was introduced at ASTRO in 2016, at least 8...

Read more